Interestingly, AIM2−/− STZ-injected mice display increased T1D incidence, augmented intestinal permeability and bacterial translocation to PLNs, which leads to a proinflammatory response mediated by Th1 and Tc1 cells. This evidence concerns the gene AIM2 and type 1 diabetes mellitus.